M&A Deal Summary

Natus Acquires Hawaii Medical

On July 6, 2009, Natus acquired medical products company Hawaii Medical for 3M USD

Acquisition Highlights
  • This is Natus’ 3rd transaction in the Medical Products sector.
  • This is Natus’ 9th largest (disclosed) transaction.
  • This is Natus’ 3rd transaction in the United States.
  • This is Natus’ 1st transaction in Hawaii.

M&A Deal Summary

Date 2009-07-06
Target Hawaii Medical
Sector Medical Products
Buyer(s) Natus
Deal Type Add-on Acquisition
Deal Value 3M USD

Target

Hawaii Medical

Honolulu, Hawaii, United States
Hawaii Medical LLC is a manufacturer and marketer of single-use disposable products sold into the NICU and nursery in hospitals.

Search 193,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Natus

Middleton, Wisconsin, United States

website


Category Company
Founded 1987
Sector Medical Products
Revenue 473M USD (2021)
DESCRIPTION

Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Natus was founded in 1987 and is based in Pleasanton, California.


DEAL STATS #
Overall 4 of 12
Sector (Medical Products) 3 of 11
Type (Add-on Acquisition) 4 of 9
State (Hawaii) 1 of 1
Country (United States) 3 of 8
Year (2009) 1 of 2
Size (of disclosed) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-03 NeuroCom International

Clackamas, Oregon, United States

NeuroCom International, Inc. is a developer and marketer of computerized systems for the assessment and rehabilitation of balance and mobility disorders.

Buy $18M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-14 Alpine Biomed

Fountain Valley, California, United States

Alpine Biomed Corp. is a provider of specialty diagnostic devices for the neurology clinical market.

Buy $43M